share_log

Ayala Pharmaceuticals (NASDAQ:ADXS) Receives New Coverage From Analysts at StockNews.com

Ayala Pharmaceuticals (NASDAQ:ADXS) Receives New Coverage From Analysts at StockNews.com

阿亚拉制药(纳斯达克股票代码:ADXS)获得StockNews.com分析师的新报道
kopsource ·  2023/03/22 04:26

Equities research analysts at StockNews.com began coverage on shares of Ayala Pharmaceuticals (NASDAQ:ADXS – Get Rating) in a research report issued to clients and investors on Tuesday. The brokerage set a "sell" rating on the stock.

StockNews.com的股票研究分析师开始报道以下股票 阿亚拉制药(纳斯达克股票代码:ADXS — 获取评级) 在周二发布给客户和投资者的研究报告中。该经纪公司对该股设定了 “卖出” 评级。

Ayala Pharmaceuticals Price Performance

阿亚拉制药的价格表现

About Ayala Pharmaceuticals

关于阿亚拉制药

(Get Rating)

(获取评级)

Advaxis, Inc is a biotechnology company, which engages in the discovery, development and commercialization of cancer immunotherapies. It manages platform technology that utilizes live attenuated Listeria monocytogenes bioengineered to secrete antigen or adjuvant fusion proteins. The firm has four franchises in various stages of clinical and pre-clinical development, namely: HPV-associated cancers, prostate cancer, neoantigen therapy and hotspot mutation therapy.

Advaxis, Inc是一家生物技术公司,从事癌症免疫疗法的发现、开发和商业化。它管理的平台技术利用活的减毒单核细胞增生李斯特菌分泌抗原或辅助融合蛋白。该公司拥有四个处于不同临床和临床前开发阶段的特许经营权,即:人乳头瘤病毒相关癌症、前列腺癌、新抗原疗法和热点突变疗法。

Featured Stories

精选故事

  • Get a free copy of the StockNews.com research report on Ayala Pharmaceuticals (ADXS)
  • On Holding AG Sprints Higher on Margin Expansion and Guidance
  • Price Growth & Yield: For That Magical Combo, Leave the U.S.
  • Game-Changing News For Tesla Investors
  • DOW New Hghs Coming Sooner Than Later
  • The Tide Is Turning For Harley-Davidson
  • 免费获取 StockNews.com 关于阿亚拉制药(ADXS)的研究报告的副本
  • On Holding AG 在利润率扩张和指导下冲刺走高
  • 价格增长和收益率:对于那个神奇的组合,离开美国
  • 对于特斯拉投资者来说,改变游戏规则的新闻
  • 道琼斯指数新高迟早会到来
  • 哈雷戴维森的潮流正在转向

Receive News & Ratings for Ayala Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ayala Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.

接收《阿亚拉制药日报》的新闻和评级 -在下面输入您的电子邮件地址,通过Marketbeat.com的免费每日电子邮件时事通讯接收Ayala Pharmicals及相关公司的最新新闻和分析师评级的简明每日摘要。

译文内容由第三方软件翻译。


以上内容仅用作资讯或教育之目的,不构成与富途相关的任何投资建议。富途竭力但不能保证上述全部内容的真实性、准确性和原创性。
    抢沙发